Physician profile
Ashok Kumar Tyagi
NPI 1912113804
$2,894.45
in general payments reported to CMS, 2019-2025
9 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.24 · 2021: $56.71 · 2022: $145 · 2023: $405 · 2024: $1,122 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,127 · Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,126.69 |
| Food and Beverage | $551.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,207.15 | 2024-2025 | Single Use Suction Valve (Sterile), Vizishot 2 Flex |
| Abbott Laboratories | $448.28 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Inspire Medical Systems, INC. | $72.17 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $38.46 | 2021-2023 | Trelegy Ellipta |
| Harmony Biosciences LLC | $35.71 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $28.88 | 2023 | Uptravi, Opsumit |
| Abiomed | $26.81 | 2025 | |
| Novo Nordisk INC | $22.75 | 2023 | Wegovy |
| Emd Serono, INC. | $14.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Tyagi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.